Nasdaq - Delayed Quote USD

Janus Henderson Global Life Sciences Fund (JFNAX)

71.44 -0.30 (-0.42%)
At close: May 10 at 8:00 PM EDT
Loading Chart for JFNAX
DELL
  • Previous Close 71.74
  • YTD Return 3.45%
  • Expense Ratio 0.80%
  • Category Health
  • Last Cap Gain 24.00
  • Morningstar Rating
  • Morningstar Risk Rating Above Average
  • Sustainability Rating
  • Net Assets 5.1B
  • Beta (5Y Monthly) 0.74
  • Yield 0.02%
  • 5y Average Return --
  • Holdings Turnover 34.00%
  • Last Dividend 0.02
  • Inception Date Dec 31, 1998

The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio management believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.

Janus Henderson

Fund Family

Health

Fund Category

5.1B

Net Assets

1998-12-31

Inception Date

Performance Overview: JFNAX

Trailing returns as of 5/10/2024. Category is Health.

YTD Return

JFNAX
3.45%
Category
7.95%
 

1-Year Return

JFNAX
8.16%
Category
30.16%
 

3-Year Return

JFNAX
4.65%
Category
16.10%
 

5-Year Return

JFNAX
11.00%
Category
15.71%
 

People Also Watch

Holdings: JFNAX

Top 10 Holdings (37.34% of Total Assets)

SymbolCompany% Assets
LLY
Eli Lilly and Company 6.63%
UNH
UnitedHealth Group Incorporated 5.96%
NOVO-B.CO
Novo Nordisk A/S 4.81%
MRK
Merck & Co., Inc. 3.56%
AZN.L
AstraZeneca PLC 3.56%
ABBV
AbbVie Inc. 3.21%
ABT
Abbott Laboratories 2.49%
SAN.PA
Sanofi 2.46%
VRTX
Vertex Pharmaceuticals Incorporated 2.37%
BSX
Boston Scientific Corporation 2.29%

Sector Weightings

SectorJFNAX
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: JFNAX

Research Reports: JFNAX

Top Mutual Funds